◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CAH

Cardinal Health Inc (CAH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Distributors · DATA UPDATED 2026-07-14

Cardinal Health Inc (CAH) operates in the Health Care Distributors industry and is headquartered in Dublin, United States with about 53,084 employees. Its market capitalization is roughly $53 billion. In the fiscal year ended 2025-06-30, CAH reported $222.6B in revenue and $1.6B in net income.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.

Interactive charts & full statements → Open the CAH valuation workbench →

CAH Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
Total Revenue$250.5B$222.6B$226.8B$205.0B$181.3B$162.5B$152.9B$145.5B$136.8B$130.0B$121.5B$102.5B$91.1B$101.1B$107.6B$102.6B$98.5B$96.0B$87.4B$86.9B$79.7B
Gross Profit$9.2B$8.2B$7.4B$6.9B$6.5B$6.8B$6.9B$6.8B$7.2B$6.5B$6.5B$5.7B$5.2B$4.9B$4.5B$4.2B$3.8B$5.5B$5.6B$5.2B$5.3B
Gross Margin %3.7%3.7%3.3%3.4%3.6%4.2%4.5%4.7%5.2%5.0%5.4%5.6%5.7%4.9%4.2%4.0%3.8%5.8%6.5%6.0%6.6%
Operating Income (EBIT)$2.3B$2.3B$1.2B$752M($607M)$472M($4.1B)$2.1B$126M$2.1B$2.5B$2.2B$1.9B$996M$1.8B$1.5B$1.3B$1.3B$1.4B$1.4B$1.8B
Operating Margin %0.9%1.0%0.5%0.4%-0.3%0.3%-2.7%1.4%0.1%1.6%2.0%2.1%2.1%1.0%1.7%1.5%1.3%1.3%1.6%1.6%2.3%
Net Income$1.6B$1.6B$852M$330M($938M)$611M($3.7B)$1.4B$256M$1.3B$1.4B$1.2B$1.2B$334M$1.1B$959M$642M$1.2B$1.3B$1.9B$1.0B
Net Margin %0.6%0.7%0.4%0.2%-0.5%0.4%-2.4%0.9%0.2%1.0%1.2%1.2%1.3%0.3%1.0%0.9%0.7%1.2%1.5%2.2%1.3%
EBITDA$3.0B$3.1B$2.0B$1.4B$55M$1.3B($2.6B)$3.0B$1.1B$2.8B$3.1B$2.6B$2.4B$1.4B$2.1B$1.9B$1.6B$1.6B$1.7B$1.8B$2.2B
Earnings Per Share (EPS)$6.56$6.45$3.45$1.26$-3.36$2.08$-12.60$4.53$0.81$4.03$4.32$3.63$3.38$0.97$3.06$2.72$1.78$3.19$3.57$4.77$2.33
Shares Outstanding (M)236M242M247M262M279M294M293M301M315M320M330M335M345M344M349M352M361M362M364M405M428M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CAH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$60.9B$65.4B$64.0B$60.2B$54.9B$55.3B$52.3B$59.7B
Gross Profit$2.5B$2.2B$2.3B$2.2B$2.1B$1.9B$1.9B$1.9B
Gross Margin %4.1%3.4%3.6%3.7%3.9%3.5%3.6%3.1%
Operating Income (EBIT)$509M$707M$668M$428M$730M$549M$568M$408M
Operating Margin %0.8%1.1%1.0%0.7%1.3%1.0%1.1%0.7%
Net Income$399M$471M$450M$239M$506M$400M$416M$236M
Net Margin %0.7%0.7%0.7%0.4%0.9%0.7%0.8%0.4%
EBITDA$741M$707M$911M$667M$946M$738M$755M$578M
Earnings Per Share (EPS)$1.69$1.99$1.88$1.00$2.10$1.65$1.70$0.96
Shares Outstanding (M)236M237M239M240M241M243M245M245M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CAH Free Cash Flow History

Cash flowTTM → 2026-03-312025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
Cash from Operations (CFO)$5.0B$2.4B$3.8B$2.8B$3.1B$2.4B$2.0B$2.7B$2.8B$1.2B$3.0B$2.5B$2.5B$1.7B$1.2B$1.4B$2.1B$1.6B$1.5B$1.2B$2.1B
Capital Expenditures (CapEx)$617M$547M$511M$481M$387M$400M$375M$328M$384M$387M$465M$300M$249M$195M$263M$291M$256M$533M$376M$357M$443M
Free Cash Flow (FCF)$4.4B$1.9B$3.3B$2.4B$2.7B$2.0B$1.6B$2.4B$2.4B$797M$2.5B$2.2B$2.3B$1.5B$913M$1.1B$1.9B$1.0B$1.1B$866M$1.7B
FCF Margin %1.8%0.8%1.4%1.1%1.5%1.2%1.0%1.6%1.7%0.6%2.1%2.2%2.5%1.5%0.9%1.1%1.9%1.1%1.3%1.0%2.1%
Dividends Paid$491M$494M$499M$525M$559M$573M$569M$577M$581M$577M$512M$460M$415M$353M$300M$274M$253M$200M$173M$144M$102M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CAH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$1.8B$686M$973M$1.5B$2.9B($400M)($1.6B)$2.1B
Capital Expenditures (CapEx)$146M$131M$108M$232M$126M$99M$90M$193M
Free Cash Flow (FCF)$1.7B$555M$865M$1.3B$2.8B($499M)($1.7B)$1.9B
FCF Margin %2.8%0.9%1.4%2.1%5.1%-0.9%-3.3%3.2%
Dividends Paid$120M$122M$129M$120M$124M$122M$128M$122M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CAH Balance Sheet History

Balance sheet2026-03-312025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
Total Assets$56.7B$53.1B$45.1B$43.3B$43.9B$44.5B$40.8B$41.0B$40.0B$40.1B$34.1B$30.1B$26.0B$25.8B$24.3B$22.8B$20.0B$25.1B$23.4B$23.2B$23.4B
Cash & Cash Equivalents$3.9B$3.9B$5.1B$4.1B$4.7B$3.4B$2.8B$2.5B$1.8B$6.9B$2.4B$4.6B$2.9B$1.9B$2.3B$1.9B$2.8B$1.2B$1.3B$1.3B$1.2B
Total Liabilities$59.4B$55.8B$48.3B$46.3B$44.6B$42.7B$39.0B$34.6B$33.9B$33.3B$27.6B$23.9B$19.6B$19.8B$18.0B$17.0B$14.7B$16.4B$15.7B$15.8B$14.9B
Total Debt (Short + Long-Term)$8.9B$8.7B$5.2B$4.8B$5.4B$6.3B$6.8B$8.0B$9.0B$10.4B$5.5B$5.5B$4.0B$3.9B$2.9B$2.5B$2.1B$3.6B$3.8B$3.5B$2.8B
Total Shareholders' Equity($2.8B)($2.8B)($3.2B)($3.0B)($709M)$1.8B$1.8B$6.3B$6.1B$6.8B$6.6B$6.3B$6.4B$6.0B$6.2B$5.8B$5.3B$8.7B$7.7B$7.4B$8.5B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CAH viewer.

Other Companies in Health Care Distributors

← CAGAll stocksCAI →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.